Laura García-Vicente

Laura García-Vicente
  • Doctor of Philosophy
  • University of Salamanca

About

10
Publications
817
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
78
Citations
Current institution
University of Salamanca
Additional affiliations
July 2016 - August 2021
Institut Pasteur
Position
  • Intern
October 2016 - June 2017
Centro Nacional de Biotecnología
Position
  • Master's Student
October 2017 - November 2021
University of Salamanca
Position
  • PhD Student
Education
September 2016 - June 2017
Autonomous University of Madrid
Field of study
  • Biomolecules and Cell Dynamics
September 2012 - June 2016
University of Salamanca
Field of study
  • Biology

Publications

Publications (10)
Preprint
Glioblastoma (GBM) is an aggressive tumor with very bad prognosis. The urgent need to find new effective therapies is challenged by the unique characteristics of GBM, including high intra and intertumoral heterogeneity. Using single-nucleus transcriptomics (snRNA-seq), we characterized the panorama of a preclinical immunocompetent murine model base...
Article
Full-text available
Background Glioblastoma is the most aggressive primary brain tumour and has a very poor prognosis. Inhibition of c-Src activity in glioblastoma stem cells (GSCs, responsible for glioblastoma lethality) and primary glioblastoma cells by the peptide TAT-Cx43266–283 reduces tumorigenicity, and boosts survival in preclinical models. Because c-Src can m...
Article
Full-text available
Background: Malignant gliomas are the most frequent primary brain tumors and remain among the most incurable cancers. Although the role of the gap junction protein, connexin43, has been deeply investigated in malignant gliomas, no compounds have been reported with the ability to recapitulate the tumor suppressor properties of this protein in in vi...
Preprint
Full-text available
Glioblastoma is the most aggressive primary brain cancer, with a median survival of 1 to 2 years. These tumours contain glioma stem cells (GSCs), which are highly tumorigenic, resistant to conventional therapies, and exhibit metabolic plasticity to adapt to challenging environments. GSCs can be specifically targeted by a short cell-penetrating pept...
Conference Paper
Full-text available
Introduction Connexin43 (Cx43), the main gap junction channel-forming protein in astrocytes, is downregulated in malignant gliomas. These tumours are composed of a heterogeneous population of cells that include many with stem cell-like properties, called glioma stem cells (GSCs). Interestingly, restoring Cx43 in these cells reverses GSC phenotype a...
Article
Full-text available
Here we present a protocol to study intracellular protein-protein interactions that is based on the widely used biotin-avidin pull-down system. The modification presented includes the combination of this technique with cell-penetrating sequences. We propose to design cell-penetrating baits that can be incubated with living cells instead of cell lys...

Network

Cited By